Explore

Trendline Trendline
AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements
Trendline Trendline
Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences

Iambic to Engage Investors at Upcoming Healthcare and Technology Conferences
Trendline Trendline
AI Breakthroughs in Structural Biology Enhance Protein Design

AI Breakthroughs in Structural Biology Enhance Protein Design

AI Breakthroughs in Structural Biology Enhance Protein Design
Trendline Trendline
Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development
Trendline Trendline
ParcelBio Secures $13M for mRNA Platform Development, Targets Autoimmune Diseases

ParcelBio Secures $13M for mRNA Platform Development, Targets Autoimmune Diseases

ParcelBio Secures $13M for mRNA Platform Development, Targets Autoimmune Diseases
Trendline Trendline
Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins

Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins

Fujifilm Unveils New Screening Platform for Cyclic Peptides Targeting Membrane Proteins
Trendline Trendline
FDA Reverses Stance on Atara and Pierre Fabre's Cell Therapy Following Leadership Change

FDA Reverses Stance on Atara and Pierre Fabre's Cell Therapy Following Leadership Change

FDA Reverses Stance on Atara and Pierre Fabre's Cell Therapy Following Leadership Change
Trendline Trendline
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy
Trendline Trendline
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Trendline Trendline
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones

Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones

Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Trendline Trendline
LenioBio and Twist Bioscience Collaborate to Enhance AI Drug Discovery

LenioBio and Twist Bioscience Collaborate to Enhance AI Drug Discovery

LenioBio and Twist Bioscience Collaborate to Enhance AI Drug Discovery
Trendline Trendline
LenioBio and Twist Bioscience Collaborate to Enhance AI-Driven Drug Discovery

LenioBio and Twist Bioscience Collaborate to Enhance AI-Driven Drug Discovery

LenioBio and Twist Bioscience Collaborate to Enhance AI-Driven Drug Discovery